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ABSTRACT Synchrotron x-ray diffraction patterns from macular corneal dystrophy (MCD) corneas contain an unusual
reflection that arises because of an undefined ultrastructure with a periodic repeat in the region of 4.6 A. In this study, we
compared the wide-angle x-ray diffraction patterns obtained from four normal human corneas and four MCD corneas.
Moreover, portions of two of the MCD corneas were pretreated with a specific glycosidase to shed light on the origin of the
4.6 A reflection. None of the normal corneas produced an x-ray reflection in the region of 4.6 A, whereas all four of the MCD
corneas did (MCD type I at 4.65 A and 4.63 A, MCD type 11 at 4.63 A and 4.67 A). This reflection was diminished after
incubation of the MCD tissues with either chondroitinase ABC or N-glycanase. The findings indicate that glycosaminoglycans
or proteoglycans contribute to the unusual MCD x-ray reflection and hence most likely contain a periodic 4.6 A ultrastructure.
Furthermore, the results imply that periodic 4.6 A MCD ultrastructures reside in either intact, unsulfated lumican molecules
and regions of the CS/DS-containing molecules or in a region of a hybrid macromolecular aggregate formed by the interaction
of the two molecules.
INTRODUCTION
Glycosaminoglycans and proteoglycans play many physio-
logically essential roles. Those proteoglycans that reside in
connective tissues are particularly important because of
their influence on the ultrastructure and biomechanics of the
extracellular connective tissue matrix. Seemingly simple
defects of the glycosaminoglycan or proteoglycan metabo-
lism in various connective tissues-most notably cartilage
and cornea-underlie such disabling conditions as osteoar-
thritis, rheumatoid arthritis, disc degeneration, and the cor-
neal mucopolysaccharidoses. One affliction whose patho-
genesis has been linked to an erroneous glycosaminoglycan
metabolism is the potentially blinding human condition
macular corneal dystrophy (MCD) (Klintworth, 1994;
Quantock, 1994). Classically, this autosomal recessive in-
herited trait presents within the first decade of life and
becomes symptomatically advanced by the third decade.
The clinical course involves the cornea becoming progres-
sively cloudy, with initial, central, superficial deposits even-
tually extending posteriorly and peripherally (Klintworth,
1980). The resultant visual disturbance is most successfully
treated with a corneal transplantation.
Opacification of the corneal stroma in MCD is due ulti-
mately to a breakdown in the regular organization of the
stromal collagen fibrils-an essential condition for tissue
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transparency (Maurice, 1957). Typical MCD ultrastructural
abnormalities include an accumulation of glycosaminogly-
can (Klintworth and Vogel, 1964; Morgan, 1966; Hassell
et al., 1980; Meek et al., 1989) and fibrillogranular deposits
(Snip et al., 1973; Edward et al., 1990; Quantock et al.,
1993b) in the stromal matrix, the presence of stromal lacu-
nae (Meek et al., 1989), occasional pockets of large diam-
eter collagen fibrils (Quantock et al., 1993b), and a com-
paction of the stromal collagen fibrils (Quantock et al.,
1990), resulting in a thin central MCD cornea (Ehlers and
Bramsen, 1978; Donnenfeld et al., 1986).
The normal human comeal stroma contains two main
types of proteoglycan, lumican and decorin. Lumican con-
sists of a core protein to which one or two side chains of
keratan sulfate (KS) are covalently attached (Gregory et al.,
1982; Midura and Hascall, 1989; Blochberger et al., 1992),
and decorin consists of a core protein and a glycosamino-
glycan side chain that is a mixture of chondroitin sulfate
(CS) and dermatan sulfate (DS) (Axelsson and Heinegard,
1975; Midura and Hascall, 1989; Li et al., 1992). Both types
of proteoglycan are intimately associated with the stromal
collagen fibrils (Scott and Haigh, 1985; Meek et al., 1986)
and play important, although not yet totally clear, functional
roles in governing stromal architecture (Borcherding et al.,
1975; Scott and Haigh, 1985; Hahn and Birk, 1992; Rada
et al., 1993; Cornuet et al., 1994).
Immunochemical criteria dictate that MCD patients fall
into one of two main subgroups that are clinically indistin-
guishable (Yang et al., 1988; Edward et al., 1988). Briefly,
the cornea and serum of the majority of MCD patients
contain no normally sulfated KS, a glycosaminoglycan eas-
ily identified by a monoclonal anti-KS antibody in an en-
zyme-linked immunosorbent assay (ELISA) (Klintworth
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et al., 1986; Thonar et al., 1986); these patients are desig-
nated as suffering from MCD typeI. The primary defect in
MCD type I is assumed to occur in the synthetic pathway of
the KS-containing proteoglycans (Klintworth and Smith,
1977; Hassell et al., 1980; Nakazawa et al., 1984) and may
involve an incomplete glycosaminoglycan sulfation process
(Hassell et al., 1980; Nakazawa et al., 1984; Midura et al.,
1990). Some MCD patients demonstrate detectable levels of
normally sulfated KS in their serum and/or cornea and are
classified as MCD type II sufferers (Yang et al., 1988;
Edward et al., 1988). As most of the KS-containing mole-
cules present in serum are products of the degradation of
proteoglycans in cartilage, the absence of normally sulfated
KS in the serum of patients with MCD type I also indicates
that KS in cartilage is not normally sulfated, a contention
that has now been supported by direct analysis of a cartilage
biopsy from a patient with MCD type I (Edward et al.,
1990). Some studies have documented that MCD patients
synthesize abnormal CS/DS; larger than normal and over-
sulfated CS/DS proteoglycans have been documented in
MCD type I corneas (Nakazawa et al., 1984), and a MCD
type II cornea has been reported to produce smaller than
normal DS proteoglycans (Midura et al., 1990). In addition,
histological work has suggested that CS/DS proteoglycans
accumulate and aggregate in both MCD types I and II
corneas (Meek et al., 1989; Quantock et al., 1990).
Corneal stroma produces an x-ray diffraction pattern, the
wide-angle component of which relates to the arrangement
of atoms and groups of atoms into molecules, and of colla-
gen molecules into fibrils (Meek et al., 1991). Previously we
documented a wide-angle x-ray diffraction ring arising from
a periodicity in the region of 4.6 A that was unique to
corneas with MCD (Quantock et al., 1992). Since that time,
a similar x-ray reflection has been documented in scarred
rabbit cornea (Rawe et al., 1994), another tissue in which
abnormally sulfated preoteglycans are known to exist (Has-
sell et al., 1983). In our previous work, we postulated that
proteoglycan or glycosaminoglycan structures could be the
origin of the unusual 4.6 A reflection in MCD corneas, but
could offer only circumstantial evidence for our contention
(Quantock et al., 1992). The present study attempts to
identify the molecule or molecules that contain 4.6 A peri-
odic ultrastructures in MCD corneas.
MATERIALS AND METHODS
Normal corneas
The four normal human corneas were obtained post-mortem from a 91-
year-old male with no known ocular problems and a 82-year-old female
with a history of cataracts. Eyes were enucleated within 6 h of death and
stored in a moist chamber. They were examined on the synchrotron within
5 days of enucleation.
MCD patients
Four patients with a clinical diagnosis ofMCD were included in the study.
Blood was drawn from each patient and the serum isolated. The concen-
tration of antigenic KS in serum was measured by a previously described
ELISA (Klintworth et al., 1986; Thonar et al., 1986), which uses an
anti-KS monoclonal antibody (1/20/5-D-4, a gift from Dr. Bruce Caterson,
University of North Carolina, Chapel Hill, NC) specific for a highly
sulfated epitope on KS chains. Based on the results of the analyses, two of
the patients (case 1, age 22; case 2, age unknown) were classified as having
MCD type I (<10 ng KS/ml). The other two patients (case 3, age 37; case
4, age 27) had normal levels of antigenic KS in serum (284 ng KS/ml and
273 ng KS/ml, respectively) and thus were classified as having MCD
type II.
Enzyme digests of MCD corneas
Small corneal portions (-2mm2) were dissected from the two MCD type
I specimens and one of the MCD type H specimens. These frozen speci-
mens were thawed and fixed for 25 min at 4°C in 2.5% formalin in a 25
mM sodium acetate buffer. Several histochemical investigations (Scott and
Haigh, 1985; Meek et al., 1989; Quantock et al., 1990)have shown that this
fixation protocol prevents stromal proteoglycans from leaking out of the
cornea during immersion in an enzyme buffer. After a brief wash in the
sodium acetate buffer, specimens were incubated for 5 h at 400C in a buffer
(Tris, 0.25 M) containing 0.5 mg/mi bovine serum albumin, 0.33 M sodium
acetate, 0.5 M sodium chloride, 0.01% type H-S soybean trypsin inhibitor,
5 mM acid-free EDTA, and 2.5 mM benzamidine, pH 8.0 (Scott and Haigh,
1985), with or without an enzyme. A portion of one of the MCD type I
specimens (case 1) was incubated in the buffer containing chondroitinase
ABC (2.5 units/ml; Sigma Chemical Co., St. Louis, MO), an enzyme that
degrades CS/DS chains into their constituent disaccharides. A portion of
the other MCD type I cornea (case 2) was incubated in the enzyme buffer
alone to check that glycosaminoglycans did not leak out of the stroma of
their own accord, and a portion of one of the MCD type H corneas (case
3) was incubated in the buffer containing N-glycanase (5 units/ml; Gen-
zyme Corporation, Cambridge, MA), an enzyme that cleaves asparagine-
linked carbohydrate chains at 13-aspartylglycosylamine bonds and thus
releases otherwise intact KS chains from the core protein to which they are
covalently bound. After the incubations and three 5-min washes in the Tris
buffer, the specimens were stored at -80°C. After synchrotron analysis all
of the incubated and non-incubated corneal specimens were digested with
papain. The concentrations of antigenic KS (quantified by the previously
described ELISA), total sulfated glycosaminoglycan as quantified by the
dimethylmethyllene blue method (Chandrasekhar et al., 1987), and colla-
gen (measured as hydroxyproline; Hauselmann et al., 1994) in the digest
were measured to determine what effect each specific glycosidase had on
CS/DS and KS in the tissue.
Synchrotron x-ray diffraction
Synchrotron x-ray diffraction patterns were obtained at the National Syn-
chrotron Light Source (Brookhaven National Laboratory, New-York). The
specimen-detector distance was 22 cm, the wavelength of radiation was
1.0936 A, and the energy of the storage ring was 2584 MeV. A 10 x 10
cm two-dimensional, multi-wire, position-sensitive detector, interfaced
with a programmable histogramming frame store, was used to record
diffraction images from corneal specimens (Capel, 1993). Images were
acquired over 60-s intervals and corrected for detector response inhomo-
geneities. The patterns revealed no angular dependence and, thus, were
circularly averaged about the beam center to yield radial diffraction pro-
files. Background radial profiles from empty sample holders were similarly
obtained and subtracted from corneal profiles after being scaled for differ-
ences in incident flux, sample transmission, and instrumental dead time.
The 51.5 A lamellar spacing of cholesterol myristate was used to calibrate
the system. Radial profiles were obtained from the four untreated MCD
specimens, the two companion enzyme-digested portions of MCD speci-
mens 1 and 3, the corneal portion from specimen 2 that had been incubated
in the enzyme buffer alone, and the four normal human corneas. To ensure
against storage-induced artifacts, one of the freshly excised normal human
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corneas was examined in a slightly dehydrated state and another after
freezing and thawing.
RESULTS
The radial intensity profiles of the x-ray diffraction patterns
from all four normal human corneas (Fig. 1) demonstrate a
main peak at approximately S = 0.055 A-. In each case
this peak arises because of the regular spacing of collagen
molecules in the corneal stroma; converted to real space,
this S value corresponds to an intermolecular Bragg spacing
of 18.2 ± 0.9 A (the confidence limits are quoted as the
accuracy with which the position of a peak could be mea-
sured, converted to real space). To be consistent with pre-
vious work (Meek et al., 1991; Meek and Leonard, 1993)
herein we quote values for the intermolecular Bragg spac-
ing. This does not take into account the mode of packing of
the collagen molecules. If one assumes pseudohexagonal
packing, the most common arrangement for a noncrystalline
assembly of rodlike molecules (Maroudas et al., 1991), the
intermolecular Bragg spacing should be multiplied by a
factor of 1.11 to obtain a value for the actual spacing of the
collagen molecules. This factor becomes 1.15 if hexagonal
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packing is assumed, and 1.12 if liquid-like packing is as-
sumed (Meek et al., 1991; Worthington and Inouye, 1985).
As the S value increases past the intermolecular peak the
radial intensity of the x-ray diffraction patterns from the
normal human corneas increases smoothly. The lowest ra-
dial intensity profile in Fig. 1 is from a cornea that had been
air-dried for approximately 30 min; the profile demonstrates
a lower overall radial intensity as S increases, presumably
because of less water scatter. The broad shoulder evident on
this lowest radial intensity profile in the region of S = 0.22
A-l was not due to a sharp "extra" reflection. The second
highest radial intensity profile in Fig. 1 is from a normal
cornea that had been frozen then thawed; profiles on either
side of it derive from corneas that had not been frozen. The
fact that the frozen and nonfrozen radial intensity profiles
are similar strongly suggests that no freezing artifacts were
induced in the MCD corneas that would give rise to spuri-
ous x-ray reflections. This is in line with previous x-ray
work on bovine cornea carried out at the synchrotron in
Daresbury, England (Meek et al., 1991; Fullwood and
Meek, 1994).
The radial intensity profiles from the four MCD speci-
mens (Fig. 2) have profiles similar to those from normal
cornea (Fig. 1), except that the position of the intermolec-
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FIGURE 1 The radial intensity profiles of the four x-ray diffraction
patterns from four normal human corneas. The main peak at approximately
0.055 A-1 (arrow) arises from the regular spacing of the collagen mole-
cules in the corneal stroma; converted to real space, this S value coffe-
sponds to an intermolecular Bragg spacing of 18.2 A ± 0.9 A. The lowest
profile-from a cornea that had been air-dried for approximately 30
min-presumably has a lower overall radial intensity because of less water
scatter.
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FIGURE 2 The radial intensity profiles of the four x-ray diffraction
patterns from MCD specimens 1-4 have profiles similar to normal ones,
except that, because of hydration differences, the position of the intermo-
lecular peak (large arrow) varies. A sharp "extra" reflection (small arrow)
is evident as a small peak/discontinuity in the region of S = 0.21 A'.
Converted to real space, the "extra" reflection arises from periodic repeats
of 4.65 A (case 1), 4.63 A (case 2), 4.63 A (case 3), and 4.67 A (case 4).
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ular peak varies within the MCD group. This is reflective of
the various states of hydration, and hence the spacing of the
collagen molecules, of the specimens. The Bragg intermo-
lecular spacings for the MCD specimens (all with confi-
dence limits of + 1.0 A) are 14.9 A (case 1), 16.1 A (case 2),
18.1 A (case 3), and 17.6 A (case 4). As with the normal
corneas, the MCD specimen that was allowed to become
somewhat dehydrated (case 1) demonstrates a relatively low
radial intensity as S increases.
Unlike the x-ray diffraction patterns from the normal
corneas, the patterns from all four MCD specimens contain
a sharp "extra" reflection. This reflection varied in intensity
but is evident as a small peak/discontinuity in the region of
S = 0.21 A-' on the radial intensity profiles from all four
MCD specimens (Fig. 2). Converted to real space, the
"extra" reflection arises from periodic repeats of 4.65 A and
4.63 A (MCD type I) and 4.63 A and 4.67 A (MCD type II).
Previous comeal x-ray work carried out at the synchrotron
in Daresbury (Quantock et al., 1992) occasionally docu-
mented a faint MCD reflection arising from a periodicity of
approximately 9.6 A; this was marginally more prominent
at lower tissue hydrations. Two of the present MCD x-ray
patterns, recorded on a different experimental set-up in
Brookhaven, NY (MCD corneas 1 and 3) suggest a faint
reflection at around S = 0.102 to 0.105 A 1 (real space
periodicity of approximately 9.5 to 9.8 A), but because of
their very low intensity it was difficult to analyze them
further.
Figs. 3 through 5 display the individual radial intensity
profiles from three of the MCD corneas along with the
profiles from their companion MCD corneal portion, which
had been incubated in the enzyme buffer with or without a
particular glycosidase (the height discrepancy between the
traces is probably indicative of variable specimen hydration,
as is the difference in the position of the intermolecular
peaks). The 4.6 A MCD reflection is still evident on the
x-ray pattern (Fig. 3) derived from the portion of specimen
2 (MCD type I) that had been incubated in the enzyme
buffer with no enzyme present. Subsequent biochemical
analysis (Table 1) of this tissue indicated that, as predicted,
fixation in 2.5% formalin before incubation in the enzyme
buffer was sufficient to prevent glycosaminoglycans leaking
out of the cornea. Unlike the x-ray pattern from the buffer-
treated portion of specimen 2 (MCD type I) (Fig. 3), we
found that the 4.6 A reflection was diminished (Fig. 4) after
pretreatment of a portion of specimen 1 (MCD type I) with
chondroitinase ABC, indicating that CS/DS glycosamin-
oglycans are involved in the expression of the reflection.
The effectiveness of the enzyme in degrading the CS/DS
chain was confirmed by biochemical analysis of the chon-
droitinase ABC-treated specimen, which showed that more
than 90% of the sulfated CS/DS glycosaminoglycans were
lost from the tissue (Table 1). The result of the analyses of
specimen 3 (MCD type II) treated with N-glycanase is more
difficult to interpret. It is worth noting that although the
MCD type II cornea contained some normally sulfated KS
chains, these were present at only 10-20% the concentra-
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FIGURE 3 The radial intensity profiles of the x-ray diffraction patterns
from an untreated MCD type I specimen (case 2; large solid arrow) and its
companion portion, which had been incubated in the enzyme buffer alone
(large open arrow). The 4.6-A MCD reflection (small solid arrow) is still
evident after the incubation.
tion found in normal age-matched corneas, a finding con-
sistent with previous observations (Quantock et al., 1992).
Treatment of a portion of specimen 3 (MCD type II) with
N-glycanase, which separates the KS chains from the core
protein of lumican but leaves the chains otherwise intact,
did not cause a significant decrease in the tissue content of
antigenic KS (Table 1). However, we did notice a signifi-
cant diminution in the 4.6 A reflection (Fig. 5), even though
the released KS chains were retained in the tissue. In this
TABLE I The relative proportions of collagen, antigenic
keratan sulfate, and total glycosaminoglycan in MCD comeas
before and after treatment with specific glycosidases
GAG (71g) AgKS (rqg) AgKS MCD
Specimen Collagen (,g) Collagen (jig) (% GAG) subtype
1 25.0 <0.10 <0.3 I
1 * <2.1 <0.10 <0.9
2 25.6 <0.10 <0.3 I
2t 27.0 <0.10 <0.2
3 28.7 0.96 3.3 II
3§ 26.4 1.04 3.9
4 43.9 3.85 8.8 II
GAG, total glycosaminoglycan; AgKS, antigenic keratan sulfate.
*Specimen incubated in chondroitinase ABC.
* Specimen incubated in enzyme buffer alone.
§ Specimen incubated in N-glycanase.
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FIGURE 4 The radial intensity profiles of the x-ray diffraction pattems
from an untreated MCD type I specimen (case 1; large solid arrow) and its
companion portion, which had been incubated with chondroitinase ABC FIGURE 5 The r
(large open arrow). The 4.6-A MCD reflection (small solid arrow) is from an untreated I
diminished after the incubation. its companion porti
open arrow). The 4
after the incubatior
case it is important to note that the incubation of this portion
of specimen 3 (MCD type II) with N-glycanase was not
associated with a marked decrease in the CS/DS content (Fig. 1) has an
(Table 1). of the hydrated
It is remarka
DISCUSSION the intermolecu
neal specimens
The main reflection in the wide-angle x-ray diffraction 4.67 A) of the
pattern from corneal stroma arises because of the regular presence in x-I
spacing of the type I and type V collagen molecules that confirms our pi
constitute the stromal collagen fibrils (Meek et al., 1991). In 1993b) that the
this study the intermolecular Bragg spacings for all four independent of
normal human corneas (Fig. 1) are consistent at 18.2 A The absence oi
(±0.9 A). A recent synchrotron x-ray diffraction study tained from n(
(Meek and Leonard, 1993) quoted a value of 16.3 + 1.0 A advanced age o
for the intermolecular Bragg spacing of normal human Extensive sync
cornea at around physiological hydration. The higher values and dystrophic
in the present study are probably reflective of our use of 1992, 1993a) l
corneas freshly excised from cadaver eyes; our clinical MCD x-ray rei
experience shows that, typically, corneas in this condition cornea, regardl
are highly edematous (50% to 100% thicker than normal). Previously M
Meek and colleagues (Meek et al., 1991) recently showed undersulfation
that when a cornea dehydrates below physiological hydra- the 4.6 A reflec
tion, the initial water comes from between the collagen Fig. 4) clearly
fibrils, not within them. Consequently, in the present study, tion by CS/DS
the fact that the cornea which was somewhat dehydrated is especially tru
0.05 0.10 0.15 0.20 0.25
s (Ad1)
radial intensity profiles of the x-ray diffraction patterns
MCD type II specimen (case 3; large solid arrow) and
ion, which had been incubated with N-glycanase (large
4.6-A MCD reflection (small solid arrow) is diminished
n.
intermolecular Bragg spacing similar to that
I corneas is not surprising.
able, especially considering the variation in
ular Bragg spacings between the MCD cor-
(Fig. 2), how constant the position (4.63 to
unusual MCD x-ray reflection remains. Its
ray patterns from all four MCD specimens
Irevious observations (Quantock et al., 1992,
e existence of the 4.6 A x-ray reflection is
'both corneal hydration and MCD subtype.
If the 4.6 A reflection in x-ray patterns ob-
ormal corneas cannot be attributed to the
f the donors compared to the MCD patients.
:hrotron x-ray diffraction studies of normal
(Fullwood et al., 1992; Quantock et al.,
human corneas have shown that the 4.6 A
flection is not expressed by any non-MCD
less of age.
ve reasoned (Quantock et al., 1992) that the
of KS in MCD is likely the major cause of
;tion; however, the present analysis (Table 1,
indicates that the contribution to this reflec-
glycosaminoglycans is at least as great. This
Lie in MCD type I, where the unique, periodic
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4.6 A MCD ultrastructures seem predominantly to reside in
chondroitinase ABC-susceptible CS/DS glycosaminogly-
cans. From the results obtained here, it is not possible to
state unequivocally whether the unsulfated form of lumican
contributes to the 4.6 A reflection in these MCD type I
corneas.
The effect of N-glycanase incubation on the disruption of
the periodic 4.6 A ultrastructures in a portion of specimen 3
(MCD type II) provides some interesting insights regarding
the possible architecture of stromal proteoglycans in this
condition. Pretreatment with N-glycanase caused a signifi-
cant attenuation of the 4.6 A x-ray reflection; this attenua-
tion, however, was not accompanied by a significant de-
crease in the content of antigenic KS chains in the tissue.
We can safely assume that, because (as expected) CS/DS-
bearing proteoglycans were not significantly depleted by
N-glycanase incubation (Table 1), these molecules could
not, by themselves, contribute greatly to the 4.6 A reflection
produced by this particular MCD type II specimen. How-
ever, N-glycanase is known to cleave the )3-aspartylglyco-
sylamine bond between KS and the core protein of lumican
but leaves the KS chains otherwise intact. Therefore, our
findings are consistent with the interpretation that neither
individual KS chains nor individual core proteins of lumi-
can are as effective as intact lumican molecules in express-
ing the 4.6 A reflection.
Our present data indicate that glycosaminoglycans or
proteoglycans (or aggregates thereof) possess a 4.6 A peri-
odicity in MCD corneas that is not seen in normal corneas.
We cannot, however, offer any information as to the orien-
tation of the periodic 4.6 A ultrastructures; they could exist
along glycosaminoglycan chains, between glycosaminogly-
can chains, or in any manner of other orientations. Further-
more, it remains to be seen whether or not the 4.6 A x-ray
reflection in scarred rabbit corneas (Rawe et al., 1994)
arises because of abnormally sulfated proteoglycans.
Previous workers (Nakazawa et al., 1984) have suggested
that, in MCD, the CS/DS proteoglycan is probably incor-
porated into the extracellular deposits of the unsulfated KS
proteoglycan, although, as yet, no conclusive evidence ex-
ists to prove this supposition or to specify what form the
incorporation might take. Nevertheless, this contention
finds some support in histochemical studies that have pro-
vided clear evidence that the stromal matrix of MCD type I
and type II corneas contains numerous lacunae in which
large proteoglycan aggregates abound (Meek et al., 1989;
Quantock et al., 1990, 1993b). Although the exact nature of
these proteoglycan aggregates remains to be clarified, they
are known to contain a CS/DS component (Meek et al.,
1989). The data presented here-that, independently, both
chondroitinase ABC and N-glycanase cause an attenuation
of the 4.6 A reflection in MCD type I and type II corneas-
raises the intriguing possibility that some form of interac-
tion between the CS/DS-bearing proteoglycans and the in-
tact, undersulfated KS-bearing lumican may underlie the
expression of the 4.6 A reflection in MCD.
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